BMJ 2007;335:991 (10 November), doi:10.1136/bmj.39372.829676.47
Practice
Change Page
In patients allergic to penicillin, consider second and third generation cephalosporins for life threatening infections
Scott Pegler, principal pharmacist, medicines information manager1,
Brendan Healy, specialist registrar in infectious diseases and microbiology2
1 Morriston Hospital, Swansea NHS Trust, Swansea SA6 6NL ,
2 NPHS Wales, Microbiology Department, University Hospital of Wales, Cardiff CF14 4XW
Correspondence to: S Pegler scott.pegler@swansea-tr.wales.nhs.uk
| The first 150 words of the full text of this article appear below. |
Introduction
Key points
- True penicillin allergy occurs in 7-23% of patients who give a history of penicillin allergy
- The frequently cited figure of 10% cross reactivity between penicillin and cephalosporins is an overestimate
- Cross reactivity between penicillins and second and third generation cephalosporins is low and may be lower than the cross reactivity between penicillins and unrelated antibiotics
- Anaphylaxis with cephalosporins is rare (0.1-0.0001%)
- In life threatening infections such as bacterial meningitis, septicaemia, and severe respiratory tract infections, consider using second and third generation cephalosporins even in patients with a history of penicillin allergy
| |
The clinical problem
Many patients claim to be allergic to penicillin. For those
confirmed as being truly allergic (type 1 allergy, with features
of urticaria, pruritic rash, etc), the cited overall rate of
10% cross reactivity between penicillin and cephalosporins is
an overestimate.
1 For life threatening infections such as bacterial
meningitis, septicaemia, and severe respiratory tract infections
in which a non-cephalosporin antibiotic
. . . [Full text of this article]
The evidence for change
Barriers to change
How should we change our practice?
Evidence for change

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?